Literature DB >> 22728051

Role of microRNA-21 and programmed cell death 4 in the pathogenesis of human uterine leiomyomas.

J Browning Fitzgerald1, Vargheese Chennathukuzhi, Faezeh Koohestani, Romana A Nowak, Lane K Christenson.   

Abstract

OBJECTIVE: To determine whether programmed cell death 4 (PDCD-4) is altered in autologous leiomyoma and myometrial tissues and what microRNA-21's (miR-21) role is in PDCD-4 expression, apoptosis, and translation.
DESIGN: Laboratory research.
SETTING: Academic medical center. PATIENT(S): Myometrial and leiomyoma tissues from patients with symptomatic leiomyomata. INTERVENTION(S): Tissue analysis and miR-21 knockdown in cultured immortalized myometrial (UtM) and leiomyoma (UtLM) cells. MAIN OUTCOME MEASURE(S): MiR-21 and PDCD-4 mRNA and protein expression. RESULT(S): Leiomyoma tissues robustly expressed the full-length 51 kd isoform of PDCD-4, but normal myometrial tissue had negligible expression. Consistent with autologous tissues, UtLM cells expressed elevated miR-21 and a similar pattern of PDCD-4 compared with UtM cells. Knockdown of miR-21 increased PDCD-4 levels in UtM cells and UtLM cells, indicating that it can regulate PDCD-4 expression. Loss of miR-21 also increased cleavage of caspase-3 (apoptosis marker) and increased phosphorylation of elongation factor-2 (marker of reduced translation) in both cell lines. CONCLUSION(S): Elevated leiomyoma miR-21 levels are predicted to decrease PDCD-4 levels, thus leiomyomas differ from other tumors where loss of PDCD-4 is associated with tumor progression. Our studies indicate regulation of PDCD-4 expression is not a primary miR-21 function in leiomyomas, but instead miR-21 is able to impact cellular apoptosis and translation, through unknown targets, in a manner consistent with its involvement in the pathophysiology of uterine fibroids.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728051      PMCID: PMC3432744          DOI: 10.1016/j.fertnstert.2012.05.040

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  37 in total

1.  Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.

Authors:  X Wu; A Blanck; M Olovsson; B Möller; R Favini; B Lindblom
Journal:  Acta Obstet Gynecol Scand       Date:  2000-05       Impact factor: 3.636

2.  Heritability and risk factors of uterine fibroids--the Finnish Twin Cohort study.

Authors:  R Luoto; J Kaprio; E M Rutanen; P Taipale; M Perola; M Koskenvuo
Journal:  Maturitas       Date:  2000-11-30       Impact factor: 4.342

3.  The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.

Authors:  Hsin-Sheng Yang; Aaron P Jansen; Anton A Komar; Xiaojing Zheng; William C Merrick; Sylvain Costes; Stephen J Lockett; Nahum Sonenberg; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

4.  Hysterectomy rates in the United States 1990-1997.

Authors:  Cynthia M Farquhar; Claudia A Steiner
Journal:  Obstet Gynecol       Date:  2002-02       Impact factor: 7.661

5.  Tumor necrosis factor-alpha expression in human uterine leiomyoma and its down-regulation by progesterone.

Authors:  O Kurachi; H Matsuo; T Samoto; T Maruo
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

6.  Familial aggregation of uterine myomas in Japanese women.

Authors:  Fumio Sato; Mitsuru Mori; Motoi Nishi; Ryuichi Kudo; Hirotsugu Miyake
Journal:  J Epidemiol       Date:  2002-05       Impact factor: 3.211

7.  Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas.

Authors:  D D Brandon; C L Bethea; E Y Strawn; M J Novy; K A Burry; M S Harrington; T E Erickson; C Warner; E J Keenan; G M Clinton
Journal:  Am J Obstet Gynecol       Date:  1993-07       Impact factor: 8.661

8.  Telomerase immortalization of human myometrial cells.

Authors:  Jennifer Condon; Su Yin; Bobbie Mayhew; R Ann Word; W E Wright; J W Shay; William E Rainey
Journal:  Biol Reprod       Date:  2002-08       Impact factor: 4.285

9.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.

Authors:  Donna Day Baird; David B Dunson; Michael C Hill; Deborah Cousins; Joel M Schectman
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

10.  Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II.

Authors:  B Lankat-Buttgereit; C Gregel; A Knolle; A Hasilik; R Arnold; R Göke
Journal:  Mol Cell Endocrinol       Date:  2004-02-12       Impact factor: 4.102

View more
  12 in total

Review 1.  Non-coding RNAs in Uterine Development, Function and Disease.

Authors:  Warren B Nothnick
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

Review 3.  The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.

Authors:  Qiwei Yang; Aymara Mas; Michael P Diamond; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2015-04-28       Impact factor: 3.060

4.  Murine MicroRNA-214 regulates intracellular adhesion molecule (ICAM1) gene expression in genital Chlamydia muridarum infection.

Authors:  Tanvi Arkatkar; Rishein Gupta; Weidang Li; Jieh-Juen Yu; Shradha Wali; M Neal Guentzel; James P Chambers; Lane K Christenson; Bernard P Arulanandam
Journal:  Immunology       Date:  2015-06-29       Impact factor: 7.397

Review 5.  Uterine Fibroids: Hiding in Plain Sight.

Authors:  Elizabeth A Stewart; Romana A Nowak
Journal:  Physiology (Bethesda)       Date:  2022-01-01

6.  Tranilast induces MiR-200c expression through blockade of RelA/p65 activity in leiomyoma smooth muscle cells.

Authors:  Tsai-Der Chuang; Amit Rehan; Omid Khorram
Journal:  Fertil Steril       Date:  2020-03-18       Impact factor: 7.329

7.  Identification and Validation of miRNA-TF-mRNA Regulatory Networks in Uterine Fibroids.

Authors:  Xiaotong Peng; Yanqun Mo; Junliang Liu; Huining Liu; Shuo Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-03-22

8.  MicroRNA expression in Epstein-Barr virus-associated post-transplant smooth muscle tumours is related to leiomyomatous phenotype.

Authors:  Danny Jonigk; Nicole Izykowski; Lavinia Maegel; Eileen Schormann; Britta Maecker-Kolhoff; Florian Laenger; Hans Kreipe; Kais Hussein
Journal:  Clin Sarcoma Res       Date:  2013-07-06

9.  MicroRNA-15b regulates reversion-inducing cysteine-rich protein with Kazal motifs (RECK) expression in human uterine leiomyoma.

Authors:  Yichun Guan; Lankai Guo; Lawrence Zukerberg; Bo R Rueda; Aaron K Styer
Journal:  Reprod Biol Endocrinol       Date:  2016-08-17       Impact factor: 5.211

10.  Tumor characterization by ultrasound-release of multiple protein and microRNA biomarkers, preclinical and clinical evidence.

Authors:  Aloma L D'Souza; John R Chevillet; Pejman Ghanouni; Xinrui Yan; Muneesh Tewari; Sanjiv S Gambhir
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.